| Trial ID: | L0070 |
| Source ID: | NCT02303730
|
| Associated Drug: |
Exenatide
|
| Title: |
Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Diabetes Mellitus, Type 2|Non-alcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Exenatide|Drug: insulin glargine
|
| Outcome Measures: |
Change in liver fat content???%??? measured by MRS|Change in intra-abdominal visceral fat content (cm2), abdominal subcutaneous fat content (cm2), and ratio between intra-abdominal visceral fat and subcutaneous fat area by MRI|Change in glucose metabolism (fasting blood glucose, postprandial plasma glucose, HbA1c)|Change in blood lipid profile (total cholesterol, triglyceride, HDL, LDL)|Change in body weight,waist circumference and hip circumference
|
| Sponsor/Collaborators: |
Fudan University|Huadong Hospital|Shanghai Minhang Central Hospital|Shanghai 6th People's Hospital|Shanghai Changzheng Hospital
|
| Gender: |
All
|
| Age: |
18 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 4
|
| Enrollment: |
76
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
March 2015
|
| Completion Date: |
November 2017
|
| Results First Posted: |
--
|
| Last Update Posted: |
August 28, 2019
|
| Locations: |
Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China|Department of Endocrinology and Metabolism, Shanghai Minhang Central Hospital, Shanghai, Shanghai, China|Department of Endocrinology and Metabolism,Huadong Hospital, Shanghai, Shanghai, China|Department of Endocrinology and Metabolism,Shanghai 6th People's Hospital, Shanghai, Shanghai, China|Department of Endocrinology and Metabolism,Shanghai Changzheng Hospital, Shanghai, Shanghai, China
|
| URL: |
https://ClinicalTrials.gov/show/NCT02303730
|
